Loading clinical trials...
Loading clinical trials...
The objective of this human study was to evaluate the association between the specificity of anti-platelet autoantibodies and response to IVIG treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shandong University
Collaborators
NCT06721013 · Immune Thrombocytopenia (ITP)
NCT07294365 · Immune Thrombocytopenia (ITP)
NCT07175493 · Autoimmune Cytopenia, Immune Thrombocytopenia (ITP), and more
NCT06888960 · Systemic Lupus Erythematosus (SLE), Idiopathic Inflammatory Myopathy (IIM), and more
NCT06973356 · Immune Thrombocytopenia (ITP)
Qilu Hospital, Shandong University
Jinan, Shandong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions